APO Research
Talk to an analyst

APO RESEARCH · REPORT

Poloxamer 338

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Poloxamer 338 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025176 pages

Choose your research edition.

Industry ResearchPoloxamer 338 Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Poloxamer 338 Industry Growth and Trends Forecast to 203271 pages · $3,450 USDMarket StructureGlobal Poloxamer 338 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Poloxamer 338 Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Poloxamer 338 Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Poloxamer 338 market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Poloxamer 338 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Poloxamer 338 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Poloxamer 338 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Poloxamer 338 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Poloxamer 338 include BASF, Croda, Comercial Química Massó and CD Formulation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

On the production side, the report examines Poloxamer 338 output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.

On the consumption side, the report analyzes sales of Poloxamer 338 by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.

The report provides an overview of the global Poloxamer 338 market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Poloxamer 338 and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Poloxamer 338 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Poloxamer 338 market size, projected growth trends, production technologies, key applications, and end-use industries.

Poloxamer 338 Segment by Company

BASF

Croda

Comercial Química Massó

CD Formulation

Poloxamer 338 Segment by Type

Purity 99%

Purity 99.9%

Others

Poloxamer 338 Segment by Application

Cosmetic

Pharmaceuticals

Others

Poloxamer 338 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Poloxamer 338 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Poloxamer 338 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Poloxamer 338.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Poloxamer 338 market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Poloxamer 338 industry.

Chapter 3: Detailed analysis of Poloxamer 338 market competition landscape. Including Poloxamer 338 manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 7: Production/Production Value of Poloxamer 338 by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 8: Consumption of Poloxamer 338 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Poloxamer 338 Industry Trends Table 2. Poloxamer 338 Industry Drivers Table 3. Poloxamer 338 Industry Opportunities and Challenges Table 4. Poloxamer 338 Industry Restraints Table 5. Global Poloxamer 338 Production Value by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Poloxamer 338 Production Value Share by Manufacturers (2021-2026) Table 7. Global Poloxamer 338 Production by Manufacturers (Tons) & (2021-2026) Table 8. Global Poloxamer 338 Production Market Share by Manufacturers Table 9. Global Poloxamer 338 Average Price (US$/Ton) of Manufacturers (2021-2026) Table 10. Global Poloxamer 338 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Poloxamer 338 Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Poloxamer 338 Manufacturers, Product Type & Application Table 13. Global Poloxamer 338 Manufacturers Established Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Poloxamer 338 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value of 2025) Table 16. Major Manufacturers of Purity 99% Table 17. Major Manufacturers of Purity 99.9% Table 18. Major Manufacturers of Others Table 19. Global Poloxamer 338 Production by Type 2021 VS 2025 VS 2032 (Tons) Table 20. Global Poloxamer 338 Production by Type (2021-2026) & (Tons) Table 21. Global Poloxamer 338 Production by Type (2027-2032) & (Tons) Table 22. Global Poloxamer 338 Production Market Share by Type (2021-2026) Table 23. Global Poloxamer 338 Production Market Share by Type (2027-2032) Table 24. Global Poloxamer 338 Production Value by Type 2021 VS 2025 VS 2032 (Tons) Table 25. Global Poloxamer 338 Production Value by Type (2021-2026) & (Tons) Table 26. Global Poloxamer 338 Production Value by Type (2027-2032) & (Tons) Table 27. Global Poloxamer 338 Production Value Market Share by Type (2021-2026) Table 28. Global Poloxamer 338 Production Value Market Share by Type (2027-2032) Table 29. Major Manufacturers of Cosmetic Table 30. Major Manufacturers of Pharmaceuticals Table 31. Major Manufacturers of Others Table 32. Global Poloxamer 338 Production by Application 2021 VS 2025 VS 2032 (Tons) Table 33. Global Poloxamer 338 Production by Application (2021-2026) & (Tons) Table 34. Global Poloxamer 338 Production by Application (2027-2032) & (Tons) Table 35. Global Poloxamer 338 Production Market Share by Application (2021-2026) Table 36. Global Poloxamer 338 Production Market Share by Application (2027-2032) Table 37. Global Poloxamer 338 Production Value by Application 2021 VS 2025 VS 2032 (Tons) Table 38. Global Poloxamer 338 Production Value by Application (2021-2026) & (Tons) Table 39. Global Poloxamer 338 Production Value by Application (2027-2032) & (Tons) Table 40. Global Poloxamer 338 Production Value Market Share by Application (2021-2026) Table 41. Global Poloxamer 338 Production Value Market Share by Application (2027-2032) Table 42. BASF Company Information Table 43. BASF Business Overview Table 44. BASF Poloxamer 338 Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 45. BASF Poloxamer 338 Product Portfolio Table 46. BASF Recent Development Table 47. Croda Company Information Table 48. Croda Business Overview Table 49. Croda Poloxamer 338 Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 50. Croda Poloxamer 338 Product Portfolio Table 51. Croda Recent Development Table 52. Comercial Química Massó Company Information Table 53. Comercial Química Massó Business Overview Table 54. Comercial Química Massó Poloxamer 338 Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 55. Comercial Química Massó Poloxamer 338 Product Portfolio Table 56. Comercial Química Massó Recent Development Table 57. CD Formulation Company Information Table 58. CD Formulation Business Overview Table 59. CD Formulation Poloxamer 338 Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 60. CD Formulation Poloxamer 338 Product Portfolio Table 61. CD Formulation Recent Development Table 62. Global Poloxamer 338 Production by Region: 2021 VS 2025 VS 2032 (Tons) Table 63. Global Poloxamer 338 Production by Region (2021-2026) & (Tons) Table 64. Global Poloxamer 338 Production Market Share by Region (2021-2026) Table 65. Global Poloxamer 338 Production Forecast by Region (2027-2032) & (Tons) Table 66. Global Poloxamer 338 Production Market Share Forecast by Region (2027-2032) Table 67. Global Poloxamer 338 Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 68. Global Poloxamer 338 Production Value by Region (2021-2026) & (US$ Million) Table 69. Global Poloxamer 338 Production Value Share by Region (2021-2026) Table 70. Global Poloxamer 338 Production Value by Region (2027-2032) & (US$ Million) Table 71. Global Poloxamer 338 Production Value Share by Region: (2027-2032) & (US$ Million) Table 72. Global Poloxamer 338 Market Average Price (US$/Ton) by Region (2021-2026) Table 73. Global Poloxamer 338 Market Average Price (US$/Ton) by Region (2027-2032) Table 74. Global Poloxamer 338 Consumption by Region: 2021 VS 2025 VS 2032 (Tons) Table 75. Global Poloxamer 338 Consumption by Region (2021-2026) & (Tons) Table 76. Global Poloxamer 338 Consumption Market Share by Region (2021-2026) Table 77. Global Poloxamer 338 Consumption Forecasted by Region (2027-2032) & (Tons) Table 78. Global Poloxamer 338 Consumption Forecasted Market Share by Region (2027-2032) Table 79. North America Poloxamer 338 Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 80. North America Poloxamer 338 Consumption by Country (2021-2026) & (Tons) Table 81. North America Poloxamer 338 Consumption by Country (2027-2032) & (Tons) Table 82. Europe Poloxamer 338 Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 83. Europe Poloxamer 338 Consumption by Country (2021-2026) & (Tons) Table 84. Europe Poloxamer 338 Consumption by Country (2027-2032) & (Tons) Table 85. Asia Pacific Poloxamer 338 Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 86. Asia Pacific Poloxamer 338 Consumption by Country (2021-2026) & (Tons) Table 87. Asia Pacific Poloxamer 338 Consumption by Country (2027-2032) & (Tons) Table 88. South America Poloxamer 338 Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 89. South America Poloxamer 338 Consumption by Country (2021-2026) & (Tons) Table 90. South America Poloxamer 338 Consumption by Country (2027-2032) & (Tons) Table 91. Middle East & Africa Poloxamer 338 Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 92. Middle East & Africa Poloxamer 338 Consumption by Country (2021-2026) & (Tons) Table 93. Middle East & Africa Poloxamer 338 Consumption by Country (2027-2032) & (Tons) Table 94. Key Raw Materials Table 95. Raw Materials Key Suppliers Table 96. Poloxamer 338 Distributors List Table 97. Poloxamer 338 Customers List Table 98. Research Programs/Design for This Report Table 99. Authors List of This Report Table 100. Secondary Sources Table 101. Primary Sources List of Figures Figure 1. Poloxamer 338 Product Image Figure 2. Global Poloxamer 338 Production Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Poloxamer 338 Production Value (2021-2032) & (US$ Million) Figure 4. Global Poloxamer 338 Production Capacity (2021-2032) & (Tons) Figure 5. Global Poloxamer 338 Production (2021-2032) & (Tons) Figure 6. Global Poloxamer 338 Average Price (US$/Ton) & (2021-2032) Figure 7. Global Top 5 and 10 Poloxamer 338 Players Market Share by Production Value in 2025 Figure 8. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Purity 99% Image Figure 10. Purity 99.9% Image Figure 11. Others Image Figure 12. Global Poloxamer 338 Production by Type (2021 VS 2025 VS 2032) & (Tons) Figure 13. Global Poloxamer 338 Production Market Share 2021 VS 2025 VS 2032 Figure 14. Global Poloxamer 338 Production Market Share by Type (2021-2032) Figure 15. Global Poloxamer 338 Production Value by Type (2021 VS 2025 VS 2032) & (Tons) Figure 16. Global Poloxamer 338 Production Value Share 2021 VS 2025 VS 2032 Figure 17. Global Poloxamer 338 Production Value Share by Type (2021-2032) Figure 18. Cosmetic Image Figure 19. Pharmaceuticals Image Figure 20. Others Image Figure 21. Global Poloxamer 338 Production by Application (2021 VS 2025 VS 2032) & (Tons) Figure 22. Global Poloxamer 338 Production Market Share 2021 VS 2025 VS 2032 Figure 23. Global Poloxamer 338 Production Market Share by Application (2021-2032) Figure 24. Global Poloxamer 338 Production Value by Application (2021 VS 2025 VS 2032) & (Tons) Figure 25. Global Poloxamer 338 Production Value Share 2021 VS 2025 VS 2032 Figure 26. Global Poloxamer 338 Production Value Share by Application (2021-2032) Figure 27. Global Poloxamer 338 Production by Region: 2021 VS 2025 VS 2032 (Tons) Figure 28. Global Poloxamer 338 Production Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Poloxamer 338 Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Poloxamer 338 Production Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Poloxamer 338 Production Value (2021-2032) & (US$ Million) Figure 32. Europe Poloxamer 338 Production Value (2021-2032) & (US$ Million) Figure 33. Asia-Pacific Poloxamer 338 Production Value (2021-2032) & (US$ Million) Figure 34. South America Poloxamer 338 Production Value (2021-2032) & (US$ Million) Figure 35. Middle East & Africa Poloxamer 338 Production Value (2021-2032) & (US$ Million) Figure 36. North America Poloxamer 338 Consumption and Growth Rate (2021-2032) & (Tons) Figure 37. North America Poloxamer 338 Consumption Market Share by Country (2021-2032) Figure 38. U.S. Poloxamer 338 Consumption and Growth Rate (2021-2032) & (Tons) Figure 39. Canada Poloxamer 338 Consumption and Growth Rate (2021-2032) & (Tons) Figure 40. Mexico Poloxamer 338 Consumption and Growth Rate (2021-2032) & (Tons) Figure 41. Europe Poloxamer 338 Consumption and Growth Rate (2021-2032) & (Tons) Figure 42. Europe Poloxamer 338 Consumption Market Share by Country (2021-2032) Figure 43. Germany Poloxamer 338 Consumption and Growth Rate (2021-2032) & (Tons) Figure 44. France Poloxamer 338 Consumption and Growth Rate (2021-2032) & (Tons) Figure 45. U.K. Poloxamer 338 Consumption and Growth Rate (2021-2032) & (Tons) Figure 46. Italy Poloxamer 338 Consumption and Growth Rate (2021-2032) & (Tons) Figure 47. Netherlands Poloxamer 338 Consumption and Growth Rate (2021-2032) & (Tons) Figure 48. Asia Pacific Poloxamer 338 Consumption and Growth Rate (2021-2032) & (Tons) Figure 49. Asia Pacific Poloxamer 338 Consumption Market Share by Country (2021-2032) Figure 50. China Poloxamer 338 Consumption and Growth Rate (2021-2032) & (Tons) Figure 51. Japan Poloxamer 338 Consumption and Growth Rate (2021-2032) & (Tons) Figure 52. South Korea Poloxamer 338 Consumption and Growth Rate (2021-2032) & (Tons) Figure 53. Southeast Asia Poloxamer 338 Consumption and Growth Rate (2021-2032) & (Tons) Figure 54. India Poloxamer 338 Consumption and Growth Rate (2021-2032) & (Tons) Figure 55. Australia Poloxamer 338 Consumption and Growth Rate (2021-2032) & (Tons) Figure 56. South America Poloxamer 338 Consumption and Growth Rate (2021-2032) & (Tons) Figure 57. South America Poloxamer 338 Consumption Market Share by Country (2021-2032) Figure 58. Brazil Poloxamer 338 Consumption and Growth Rate (2021-2032) & (Tons) Figure 59. Argentina Poloxamer 338 Consumption and Growth Rate (2021-2032) & (Tons) Figure 60. Chile Poloxamer 338 Consumption and Growth Rate (2021-2032) & (Tons) Figure 61. Middle East & Africa Poloxamer 338 Consumption and Growth Rate (2021-2032) & (Tons) Figure 62. Middle East & Africa Poloxamer 338 Consumption Market Share by Country (2021-2032) Figure 63. Egypt Poloxamer 338 Consumption and Growth Rate (2021-2032) & (Tons) Figure 64. South Africa Poloxamer 338 Consumption and Growth Rate (2021-2032) & (Tons) Figure 65. Israel Poloxamer 338 Consumption and Growth Rate (2021-2032) & (Tons) Figure 66. Türkiye Poloxamer 338 Consumption and Growth Rate (2021-2032) & (Tons) Figure 67. GCC Countries Poloxamer 338 Consumption and Growth Rate (2021-2032) & (Tons) Figure 68. Poloxamer 338 Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Poloxamer 338 Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Purity 99%
  • Purity 99.9%
  • Others
Applications
  • Cosmetic
  • Pharmaceuticals
  • Others
Companies covered
  • BASF
  • Croda
  • Comercial Química Massó
  • CD Formulation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Poloxamer 338 Production Value Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Poloxamer 338 Production Capacity Estimates and Forecasts (2021-2032)
  5. 1.2.3 Global Poloxamer 338 Production Estimates and Forecasts (2021-2032)
  6. 1.2.4 Global Poloxamer 338 Market Average Price (2021-2032)
  7. 1.3 Assumptions and Limitations
  8. 1.4 Study Goals and Objectives
2 Global Poloxamer 338 Market Dynamics
  1. 2.1 Poloxamer 338 Industry Trends
  2. 2.2 Poloxamer 338 Industry Drivers
  3. 2.3 Poloxamer 338 Industry Opportunities and Challenges
  4. 2.4 Poloxamer 338 Industry Restraints
3 Poloxamer 338 Market by Manufacturers
  1. 3.1 Global Poloxamer 338 Production Value by Manufacturers (2021-2026)
  2. 3.2 Global Poloxamer 338 Production by Manufacturers (2021-2026)
  3. 3.3 Global Poloxamer 338 Average Price by Manufacturers (2021-2026)
  4. 3.4 Global Poloxamer 338 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Poloxamer 338 Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Poloxamer 338 Manufacturers, Product Type & Application
  7. 3.7 Global Poloxamer 338 Manufacturers Established Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Poloxamer 338 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Poloxamer 338 Players Market Share by Production Value in 2025
  11. 3.8.3 2025 Poloxamer 338 Tier 1, Tier 2, and Tier 3
4 Poloxamer 338 Market by Type
  1. 4.1 Poloxamer 338 Type Introduction
  2. 4.1.1 Purity 99%
  3. 4.1.2 Purity 99.9%
  4. 4.1.3 Others
  5. 4.2 Global Poloxamer 338 Production by Type
  6. 4.2.1 Global Poloxamer 338 Production by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Poloxamer 338 Production by Type (2021-2032)
  8. 4.2.3 Global Poloxamer 338 Production Market Share by Type (2021-2032)
  9. 4.3 Global Poloxamer 338 Production Value by Type
  10. 4.3.1 Global Poloxamer 338 Production Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Poloxamer 338 Production Value by Type (2021-2032)
  12. 4.3.3 Global Poloxamer 338 Production Value Market Share by Type (2021-2032)
5 Poloxamer 338 Market by Application
  1. 5.1 Poloxamer 338 Application Introduction
  2. 5.1.1 Cosmetic
  3. 5.1.2 Pharmaceuticals
  4. 5.1.3 Others
  5. 5.2 Global Poloxamer 338 Production by Application
  6. 5.2.1 Global Poloxamer 338 Production by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Poloxamer 338 Production by Application (2021-2032)
  8. 5.2.3 Global Poloxamer 338 Production Market Share by Application (2021-2032)
  9. 5.3 Global Poloxamer 338 Production Value by Application
  10. 5.3.1 Global Poloxamer 338 Production Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Poloxamer 338 Production Value by Application (2021-2032)
  12. 5.3.3 Global Poloxamer 338 Production Value Market Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 BASF
  2. 6.1.1 BASF Company Information
  3. 6.1.2 BASF Business Overview
  4. 6.1.3 BASF Poloxamer 338 Production, Value and Gross Margin (2021-2026)
  5. 6.1.4 BASF Poloxamer 338 Product Portfolio
  6. 6.1.5 BASF Recent Developments
  7. 6.2 Croda
  8. 6.2.1 Croda Company Information
  9. 6.2.2 Croda Business Overview
  10. 6.2.3 Croda Poloxamer 338 Production, Value and Gross Margin (2021-2026)
  11. 6.2.4 Croda Poloxamer 338 Product Portfolio
  12. 6.2.5 Croda Recent Developments
  13. 6.3 Comercial Química Massó
  14. 6.3.1 Comercial Química Massó Company Information
  15. 6.3.2 Comercial Química Massó Business Overview
  16. 6.3.3 Comercial Química Massó Poloxamer 338 Production, Value and Gross Margin (2021-2026)
  17. 6.3.4 Comercial Química Massó Poloxamer 338 Product Portfolio
  18. 6.3.5 Comercial Química Massó Recent Developments
  19. 6.4 CD Formulation
  20. 6.4.1 CD Formulation Company Information
  21. 6.4.2 CD Formulation Business Overview
  22. 6.4.3 CD Formulation Poloxamer 338 Production, Value and Gross Margin (2021-2026)
  23. 6.4.4 CD Formulation Poloxamer 338 Product Portfolio
  24. 6.4.5 CD Formulation Recent Developments
7 Global Poloxamer 338 Production by Region
  1. 7.1 Global Poloxamer 338 Production by Region: 2021 VS 2025 VS 2032
  2. 7.2 Global Poloxamer 338 Production by Region (2021-2032)
  3. 7.2.1 Global Poloxamer 338 Production by Region (2021-2026)
  4. 7.2.2 Global Poloxamer 338 Production Forecast by Region (2027-2032)
  5. 7.3 Global Poloxamer 338 Production by Region: 2021 VS 2025 VS 2032
  6. 7.4 Global Poloxamer 338 Production Value by Region (2021-2032)
  7. 7.4.1 Global Poloxamer 338 Production Value by Region (2021-2026)
  8. 7.4.2 Global Poloxamer 338 Production Value by Region (2027-2032)
  9. 7.5 Global Poloxamer 338 Market Price Analysis by Region (2021-2032)
  10. 7.6 Regional Production Value Trends (2021-2032)
  11. 7.6.1 North America Poloxamer 338 Production Value (2021-2032)
  12. 7.6.2 Europe Poloxamer 338 Production Value (2021-2032)
  13. 7.6.3 Asia-Pacific Poloxamer 338 Production Value (2021-2032)
  14. 7.6.4 South America Poloxamer 338 Production Value (2021-2032)
  15. 7.6.5 Middle East & Africa Poloxamer 338 Production Value (2021-2032)
8 Global Poloxamer 338 Consumption by Region
  1. 8.1 Global Poloxamer 338 Consumption by Region: 2021 VS 2025 VS 2032
  2. 8.2 Global Poloxamer 338 Consumption by Region (2021-2032)
  3. 8.2.1 Global Poloxamer 338 Consumption by Region (2021-2026)
  4. 8.2.2 Global Poloxamer 338 Consumption by Region (2027-2032)
  5. 8.3 North America
  6. 8.3.1 North America Poloxamer 338 Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 8.3.2 North America Poloxamer 338 Consumption by Country (2021-2032)
  8. 8.3.3 U.S.
  9. 8.3.4 Canada
  10. 8.3.5 Mexico
  11. 8.4 Europe
  12. 8.4.1 Europe Poloxamer 338 Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 8.4.2 Europe Poloxamer 338 Consumption by Country (2021-2032)
  14. 8.4.3 Germany
  15. 8.4.4 France
  16. 8.4.5 U.K.
  17. 8.4.6 Italy
  18. 8.4.7 Netherlands
  19. 8.5 Asia Pacific
  20. 8.5.1 Asia Pacific Poloxamer 338 Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 8.5.2 Asia Pacific Poloxamer 338 Consumption by Country (2021-2032)
  22. 8.5.3 China
  23. 8.5.4 Japan
  24. 8.5.5 South Korea
  25. 8.5.6 Southeast Asia
  26. 8.5.7 India
  27. 8.5.8 Australia
  28. 8.6 South America
  29. 8.6.1 South America Poloxamer 338 Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 8.6.2 South America Poloxamer 338 Consumption by Country (2021-2032)
  31. 8.6.3 Brazil
  32. 8.6.4 Argentina
  33. 8.6.5 Chile
  34. 8.6.6 Colombia
  35. 8.7 Middle East & Africa
  36. 8.7.1 Middle East & Africa Poloxamer 338 Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  37. 8.7.2 Middle East & Africa Poloxamer 338 Consumption by Country (2021-2032)
  38. 8.7.3 Egypt
  39. 8.7.4 South Africa
  40. 8.7.5 Israel
  41. 8.7.6 Türkiye
  42. 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
  1. 9.1 Poloxamer 338 Value Chain Analysis
  2. 9.1.1 Poloxamer 338 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Poloxamer 338 Production Mode & Process
  6. 9.2 Poloxamer 338 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Poloxamer 338 Distributors
  9. 9.2.3 Poloxamer 338 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst